Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

The following example illustrates stability study results for an ENDS tobacco product. Stability study results are represented in the Tobacco Product Testing (PT) domain, with PTCAT = STABILITY TESTING.

Info

The first pt.xpt dataset shows 22 consituents and parameters each as a single replicate (PTREPNUM=1), at 1 time point (PTTPT=Week 0 / PTTPTNUM=1) and from 1 set of storage conditions (STOCONID= Condition 1)

Info

NOTE TO TEAM REVIEWERS:

The example below demonstrates the required data structure of one record per analyte per replicate per test condition per timepoint to accurately represent data from a stability study.
The resulting structure would require 648 rows to illustrate the 12 analytes shown in the example study we received, done in triplicate under two test conditions at the number of timepoints in the example study.

For conciseness, we have abbreviated the examples below to demonstrate the concepts as follows:

First- we show all 12 analytes as a single replicate, at one time point and one test condition in order to illustrate the variables and terminology required to put together a stability study with assays  done in replicate at different time points and varying test conditions, even though only one record per analyte is illustrated.

Second- We show ONE analyte (moisture) in triplicate, over a series of time points and two test conditions to give a sense of what the complete data would look like.

Hopefully users could combine the information shown in both examples to construct a complete dataset containing all the records for each analyte-replicate-test condition-time point group.

Info
titleTobacco domains

DI = TO for Tobacco Product Identifiers and Descriptors

SPDEVID = SPTOBID for Sponsor Tobacco Product Identifier

DO/DU = Tobacco Product Design Parameters (PD)

LB = Tobacco Product Testing (PT) - [Would Findings be better?]

The example shown below is not an all inclusive comprehensive example.  It is meant to be illustrative of the concepts.

Shelf life study has a protocol and provides the results of shelf life studies of Vapes products over time with different conditions and analytes.  Generally there are many conditions with at least two with varying temperature, humidity, etc. The initial table shows the a number of the analytes and test conditions used in Shelf Life studies for Vapes products for one testing condition at one timepoint and one replicate.

Tobacco Product Testing (TT) is a Findings domain similar to the Laboratory Test Results domain.

PTCAS variable (in place of the LBLOINC variable) provides the accurate chemical name, structure for organic and inorganic substances.

construct an SDTM-conformant PT dataset for a stability study. Some constituent names (values of PTTESTCD/PTTEST) appear twice because they are tested separately in both e-liquid and aerosol (as indicated by PTSPEC). Note that the constituent names shown do not represent an exhaustive list of the controlled terminology that will be developed to support representation of stability studies in SDTM.

Note
  • The use of SPDEVID and PTREFID in this example on records where PTSPEC=AEROSOL indicates that a smoking machine (shown in SPDEVID) was used to perform the vaping regimen (shown in PTREFID) to produce the aerosol from the e-liquid product on records where PTSPEC=AEROSOL. Details of the smoking machine and vaping regimen are not shown in this example. For examples illustrating how to represent these concepts in SDTM, see Section 3.1.3.2, HPHCs, Other Constituents, and Smoking / Vaping Regimens.
  • PTXFN (External File Path) is used to document the location or file name within the submission that contains the lab methodology protocol used to assay the associated constituent when such methodology is too complex for the single PTMETHOD variable.
  • STOCONID is used to identify the storage conditions of the e-liquid product for the testing performed. Details of these conditions are represented in the Environmental Storage Conditions (ES) dataset example that follows the 2 PT dataset examples. 
  • In this example, the applicant chose to subcategorize some consituents and parameters using the permissible variable PTSCAT (Sub-Category of Test).
Dataset wrap
Dataset wrap
Namept
Show microbials, TAMC and TYMC (PTTEST and PTTESTCD), used in testing (aerobic plate count, mold, and yeast) using the PTCAT variable. The E-Liquid substance has the condition represented using the PTTSTCND which is E-Liquid Standard (Long Term) Condition.  
Rowcaps
Rows 1
-20:
Shows several analytes (as noted in the PTTEST) in the E-Liquid substance for the condition noted in PTTSTCND which is E-Liquid Standard (Long Term) Condition. 
Rows 2, 12, 13:Show the Nicotine, 4-(N-methyl-N-nitrosoamino)-1-(3-pyridyl)-1-butanone (NNK), and N-nitrosonornicotine analytes in the Aerosol substance represented using the PTSPEC variable.
Rows 17, 18:
, 3, 5, 7, 9, 10, 15, 17-19, 22, 24, 25, 27-31:Show the results of testing for constituents in samples of e-liquid product (PTSPEC=E-LIQUID).
Rows 2, 4, 6, 8, 11-14, 16, 20, 21, 23, 26:Show the results of testing for constituents/parameters in aerosol produced from the e-liquid product. The smoking machine is shown in SPDEVID and the regimen is shown in PTREFID.
Dataset2
RowSTUDYIDDOMAIN
PTSEQ
SPTOBID
PTREFID
SPDEVID
SPTOBID
STOCONDIDPTSEQ
PTCAS
PTREFIDPTTESTCDPTTESTPTCATPTSCAT
PTTSTCND
PTORRESPTORRESUPTLLODPTSTRESCPTSTRESNPTSTRESU
PTSPEC
PTNAM
PTSPCCND
PTXFN
PTMETHOD
PTSPECPTLLOQPTREPNUMPTDTCPTTPTPTTPTNUM
1TOB07PT111
Condition 1
VAP77777.NIC

1

11154-11-5


NICOTINENicotineSTABILITY
STUDYE-Liquid Standard (Long Term) ConditionE-LIQUID1Week 012TOB07PT2VAP77777.111154-11-5NICNicotineSTABILITY STUDYE-Liquid Standard (Long Term) ConditionAEROSOL
TESTING
35.94mg/g
35.9435.94mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023
1
Week 01
3
2TOB07PT111
3
PUFFMASTER3K
VAP77777.
Condition 1
111
2
494-97-3XXXXX

Nornicotine

STABILITY STUDYNicotine DegradantE-Liquid Standard (Long Term) ConditionE-LIQUID1Week 01
NON-INTENSE REGIMENNICOTINENicotineSTABILITY TESTING

0.1039

mg/PUFF
0.10390.1039mg/PUFFTPT LABCOTLAE01_v2.1.pdfAEROSOL0.001102-01-2023
4TOB07PT4VAP77777.1111494-52-0XXXXX

Anabasine

STABILITY STUDYNicotine DegradantE-Liquid Standard (Long Term) ConditionE-LIQUID1
Week 01
5
3TOB07PT
5
111
VAP77777.

Condition 1
11156-81-5XXXXXGlycerinSTABILITY STUDYPrimary IngredientE-Liquid Standard (Long Term) ConditionE-LIQUID
3
NORNCTN

Nornicotine

STABILITY TESTINGNicotine Degradant25.76ug/g
25.7625.76ug/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023
1
Week 01
6
4TOB07PT111
6
PUFFMASTER3K
VAP77777.
Condition 1
111
4
57-55-6XXXXXPropylene GlycolSTABILITY STUDYPrimary IngredientE-Liquid Standard (Long Term) ConditionE-LIQUID1Week 017TOB07PT7VAP77777.111165-85-0XXXXXBenzoic AcidSTABILITY STUDYAcidE-Liquid Standard (Long Term) ConditionE-LIQUID1Week 018TOB07PT8VAP77777.1111

89-78-1

confirm this one, there are two - the other is 1490-04-6

NON-INTENSE REGIMENNORNCTN

Nornicotine

STABILITY TESTINGNicotine Degradant0.0392ug/PUFF
0.03920.0392ug/PUFFTPT LABCOTLAE01_v2.1.pdfAEROSOL0.001102-01-2023Week 01
5TOB07PT111
Condition 15
GLYCRLGlycerolSTABILITY TESTINGPrimary Ingredient615.68mg/g
615.68615.68mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023
XXXXXMenthol
STABILITY STUDYFlavorantE-Liquid Standard (Long Term) ConditionE-LIQUID1
Week 01
9
6TOB07PT111
9
PUFFMASTER3K
VAP77777.
Condition 1
111XXXXXVanillin
STABILITY STUDYFlavorantE-Liquid Standard (Long Term) ConditionE-LIQUID1Week 0110TOB07PT10VAP77777.1111NNK4-(N-methyl-N-nitrosoamino)-1-(3-pyridyl)-1-butanone (NNK)STABILITY STUDYHPHCE-Liquid Standard (Long Term) ConditionE-LIQUID
6NON-INTENSE REGIMENGLYCRLGlycerolSTABILITY TESTINGPrimary Ingredient1.81mg/PUFF0.001441.811.81mg/PUFFTPT LABCOTLAE01_v2.1.pdfAEROSOL0.001102-01-2023
1
Week 01
11
7TOB07PT
11
111
VAP77777.

Condition 1
111
7
NNN

PRPYLGLYPropylene Glycol
N-nitrosonornicotine
STABILITY
STUDYHPHCE-Liquid Standard (Long Term) Condition
TESTINGPrimary Ingredient218.21mg/g
218.21218.21mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
12
8TOB07PT111
12
PUFFMASTER3K
VAP77777.
Condition 1
111NNK4-(N-methyl-N-nitrosoamino)-1-(3-pyridyl)-1-butanone (NNK)STABILITY STUDYHPHCE-Liquid Standard (Long Term) ConditionAEROSOL1Week 01
8NON-INTENSE REGIMENPRPYLGLYPropylene GlycolSTABILITY TESTINGPrimary Ingredient0.8565mg/PUFF0.000240.85650.8565mg/PUFFTPT LABCOTLAE01_v2.1.pdfAEROSOL0.001102-01-2023
13TOB07PT13VAP77777.1111NNNN-nitrosonornicotineSTABILITY STUDYHPHCE-Liquid Standard (Long Term) ConditionAEROSOL1
Week 01
14
9TOB07PT
14
111
VAP77777.

Condition 1
111
9
XXXXXMetals - NickelSTABILITY STUDYExtractables / Leachables E-Liquid Standard (Long Term) Condition

BNZOICACBenzoic AcidSTABILITY TESTINGAcid42.2ug/PUFF
42.242.2ug/PUFFTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
15
10TOB07PT
15
111
VAP77777.

Condition 1
111
10
PH

MENTHOL
pHSTABILITY STUDYE-Liquid Standard (Long Term) Condition
MentholSTABILITY TESTINGFlavorant37.53mg/g
37.5337.53mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
16
11TOB07PT111
16
PUFFMASTER3K
VAP77777.
Condition 1
111XXXXXEndotoxinSTABILITY STUDYToxinsE-Liquid Standard (Long Term) ConditionE-LIQUID1Week 01
11NON-INTENSE REGIMENMENTHOLMentholSTABILITY TESTINGFlavorant0.5881mg/PUFF0.000240.58810.5881mg/PUFFTPT LABCOTLAE01_v2.1.pdf

AEROSOL

0.001102-01-2023
17TOB07PT17VAP77777.1111XXXXXTAMCSTABILITY STUDYMicrobiologicalE-Liquid Standard (Long Term) ConditionE-LIQUID1
Week 01
18
12TOB07PT111
18
PUFFMASTER3K
VAP77777.
Condition 1
111XXXXXTYMCSTABILITY STUDYMicrobiologicalE-Liquid Standard (Long Term) ConditionE-LIQUID1Week 01
12NON-INTENSE REGIMENGLYCDOLGlycidolSTABILITY TESTINGStabilizerNOT DETECTED
0.00011NOT DETECTED

TPT LABCOTLAE01_v2.1.pdf

AEROSOL

0.001102-01-2023
19TOB07PT19VAP77777.1111XXXXXAcetaldehydeSTABILITY STUDYAldehydeE-Liquid Standard (Long Term) ConditionE-LIQUID1
Week 01
20
13TOB07PT111
20
PUFFMASTER3K
VAP77777.
Condition 1
111XXXXXAcetyl propionylSTABILITY STUDYDiketoneE-Liquid Standard (Long Term) ConditionE-LIQUID1Week 01

A Shelf Life study dataset would shows analytes done in different test conditions with replicates over time points.  In the interest of brevity for this example, only portions of the content using the TEST of Nicotine is shown in a sample of timepoints in two conditions with replicates. The weeks reflective of Week 1,  Week 2, Week 3, etc. which would align with the PTTPTNUM of 2,3, etc. are not shown for visual viewing purposes. This is an example, this provides possible tests that might be used to demonstrate how to use the datasets and variables to show what was done for the shelf-life stability study. It shows what timepoint and what type of data follows. It is important to show different test conditions for each analyte. For aerosol a machine similutaion is use so mg/puff is valid.

13NON-INTENSE REGIMENFRMLDHDFormaldehydeSTABILITY TESTING
0.0728ug/PUFF0.005490.07280.0728ug/PUFFTPT LABCOTLAE01_v2.1.pdf

AEROSOL

0.001102-01-2023Week 01
14TOB07PT111PUFFMASTER3KCondition 114NON-INTENSE REGIMENACROLNAcrolienSTABILITY TESTING
DETECTED, BELOW LLOQ
0.00928DETECTED, BELOW LLOQ

TPT LABCOTLAE01_v2.1.pdf

AEROSOL

0.001102-01-2023Week 01
15TOB07PT111
Condition 115
LACTICACLactic AcidSTABILITY TESTING
40.44ug/g
40.4440.44ug/gTPT LABCOTLEL01_v1.5.pdf

E-LIQUID

0.001102-01-2023Week 01
16TOB07PT111PUFFMASTER3KCondition 116NON-INTENSE REGIMENLACTICACLactic AcidSTABILITY TESTING
29.71ug/PUFF0.28429.7129.71ug/PUFFTPT LABCOTLAE01_v2.1.pdf

AEROSOL

0.001102-01-2023Week 01
17TOB07PT111
Condition 117
VANLLNVanillinSTABILITY TESTINGFlavorant1.12ug/g
1.121.12ug/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
18TOB07PT111
Condition 118
NNKNicotine-Derived Nitrosamine KetoneSTABILITY TESTINGHPHC0.0711ug/g
0.07110.0711ug/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
19TOB07PT111
Condition 119
NNNN-NitrosonornicotineSTABILITY TESTINGHPHC0.0852ug/g
0.08520.0852ug/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
20TOB07PT111PUFFMASTER3KCondition 120NON-INTENSE REGIMENNNKNicotine-Derived Nitrosamine KetoneSTABILITY TESTINGHPHC0.0577ug/PUFF
0.05770.0577ug/PUFFTPT LABCOTLAE01_v2.1.pdfAEROSOL0.001102-01-2023Week 01
21TOB07PT111PUFFMASTER3KCondition 121NON-INTENSE REGIMENNNNN-NitrosonornicotineSTABILITY TESTINGHPHC0.0742ug/PUFF
0.07420.0742ug/PUFFTPT LABCOTLAE01_v2.1.pdfAEROSOL0.001102-01-2023Week 01
22TOB07PT111
Condition 122
NICKELNickelSTABILITY TESTINGExtractables / Leachables0.0897ug/g
0.08970.0897ug/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
23TOB07PT111PUFFMASTER3KCondition 123NON-INTENSE REGIMENMASSMassSTABILITY TESTING
3.87mg/PUFF0.00713.873.87mg/PUFFTPT LABCOTLAE01_v2.1.pdfAEROSOL0.001102-01-2023Week 01
24TOB07PT111
Condition 124
CHROMIUMChromiumSTABILITY TESTING
NOT DETECTED

NOT DETECTED

TPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
25TOB07PT111
Condition 125
PH

pH

STABILITY TESTING
7.15

7.157.15
TPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
26TOB07PT111PUFFMASTER3KCondition 126NON-INTENSE REGIMENPHpHSTABILITY TESTING
7.24

7.247.24
TPT LABCOTLAE01_v2.1.pdfAEROSOL0.001102-01-2023Week 01
27TOB07PT111
Condition 127
ENDTXNEndotoxinSTABILITY TESTINGToxinsNOT DETECTED

NOT DETECTED

TPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
28TOB07PT111
Condition 128
AEBCTAerobic Colony CountSTABILITY TESTINGMicrobiological<1CFU/mL
<1
CFU/mLTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
29TOB07PT111
Condition 129
YSTMLDCTYeast and/or Mold Colony CountSTABILITY TESTINGMicrobiological1CFU/mL
11CFU/mLTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
30TOB07PT111
Condition 130
ACTALDAcetaldehydeSTABILITY TESTINGAldehyde7.8ug/mL
7.87.8ug/mLTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
31TOB07PT111
Condition 131
ACTPROPNAcetyl PropionylSTABILITY TESTINGDiketone32.4ug/mL
32.432.4ug/mLTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
Info

The second PT dataset shows testing for just 1 constituent (nicotine), performed in 3 replicates (note the values of PTREPNUM), at the first 3 time points of the study (as shown in PTTPT/PTTPTNUM), from 3 sets of storage conditions (STOCONID), in samples of e-liquid and aerosol (PTSPEC) in order to illustrate how those variables are used to represent their associated concepts in a stability study. 

Note
  • As in the first PT dataset, the details of the smoking machine and vaping regimen are not shown in this example. For examples illustrating how to represent these concepts in SDTM, see Section 3.1.3.2, HPHCs, Other Constituents, and Smoking/Vaping Regimens.
  • Details of the 3 conditions are represented in the ES dataset example that follows.
Dataset wrap
Namept
Dataset2
Row

STUDYID

DOMAINSPTOBIDSPDEVIDSTOCONIDPTSEQPTREFIDPTTESTCDPTTESTPTORRESPTORRESUPTSTRESCPTSTRESNPTSTRESUPTNAMPTXFNPTSPECPTREPNUMPTDTCPTTPTPTTPTNUM
1TOB07PT111
Condition 1211
NICOTINE

Nicotine

35.94mg/g35.9435.94mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID102-01-2023Week 01
2TOB07PT111
Condition 1212


NICOTINE

Nicotine35.46mg/g35.4635.46mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID202-01-2023Week 01
3TOB07PT111
Condition 1213
NICOTINENicotine35.97mg/g35.9735.97mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID302-01-2023Week 01
4TOB07PT111
Condition 1214
NICOTINENicotine35.55mg/g35.5535.55mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID103-29-2023Week 82
5TOB07PT111
Condition 1215
NICOTINENicotine35.88mg/g35.8835.88mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID203-29-2023Week 82
6TOB07PT111
Condition 1216
NICOTINENicotine35.67mg/g35.6735.67mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID303-29-2023Week 82
7TOB07PT111
Condition 1217
NICOTINENicotine36.11mg/g36.1136.11mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID107-19-2023Week 243
8TOB07PT111
Condition 1218
NICOTINENicotine35.72mg/g35.7235.72mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID207-19-2023Week 243
9TOB07PT111
Condition 1219
NICOTINENicotine35.54mg/g35.5435.54mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID307-19-2023Week 243
10TOB07PT111PUFFMASTER3KCondition 2220NON-INTENSE REGIMENNICOTINE

Nicotine

0.1039mg/PUFF0.10390.1039mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL102-01-2023Week 01
11TOB07PT111PUFFMASTER3KCondition 2221NON-INTENSE REGIMENNICOTINENicotine0.1142mg/PUFF0.11420.1142mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL202-01-2023Week 01
12TOB07PT111PUFFMASTER3KCondition 2222NON-INTENSE REGIMENNICOTINENicotine0.1282mg/PUFF0.12820.1282mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL302-01-2023Week 01
13TOB07PT111PUFFMASTER3KCondition 2223NON-INTENSE REGIMENNICOTINENicotine0.1242mg/PUFF0.12420.1242mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL103-29-2023Week 82
14TOB07PT111PUFFMASTER3KCondition 2224NON-INTENSE REGIMENNICOTINENicotine0.1084mg/PUFF0.10840.1084mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL203-29-2023Week 82
15TOB07PT111PUFFMASTER3KCondition 2225NON-INTENSE REGIMENNICOTINENicotine0.1174mg/PUFF0.11740.1174mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL303-29-2023Week 82
16TOB07PT111PUFFMASTER3KCondition 2226NON-INTENSE REGIMENNICOTINENicotine0.1374mg/PUFF0.13740.1374mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL107-19-2023Week 243
17TOB07PT111PUFFMASTER3KCondition 2227NON-INTENSE REGIMENNICOTINENicotine0.1364mg/PUFF0.13640.1364mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL207-19-2023Week 243
18TOB07PT111PUFFMASTER3KCondition 2228NON-INTENSE REGIMENNICOTINENicotine0.1264mg/PUFF0.12640.1264mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL307-19-2023Week 243
19TOB07PT111PUFFMASTER3KCondition 2229NON-INTENSE REGIMENNICOTINENicotine0.1256mg/PUFF0.12560.1256mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL102-01-2023Week 01
20TOB07PT111PUFFMASTER3KCondition 3230NON-INTENSE REGIMENNICOTINENicotine0.1236mg/PUFF0.12360.1236mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL202-01-2023Week 01
21TOB07PT111PUFFMASTER3KCondition 3231NON-INTENSE REGIMENNICOTINENicotine0.1126mg/PUFF0.11260.1126mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL302-01-2023Week 01
22TOB07PT111PUFFMASTER3KCondition 3232NON-INTENSE REGIMENNICOTINENicotine0.1334mg/PUFF0.13340.1334mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL103-29-2023Week 82
23TOB07PT111PUFFMASTER3KCondition 3233NON-INTENSE REGIMENNICOTINENicotine0.1134mg/PUFF0.11340.1134mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL203-29-2023Week 82
24TOB07PT111PUFFMASTER3KCondition 3234NON-INTENSE REGIMENNICOTINENicotine0.1125mg/PUFF0.11250.1125mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL303-29-2023Week 82
25TOB07PT111PUFFMASTER3KCondition 3235NON-INTENSE REGIMENNICOTINENicotine0.1156mg/PUFF0.11560.1156mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL107-19-2023Week 243
26TOB07PT111PUFFMASTER3KCondition 3236NON-INTENSE REGIMENNICOTINENicotine0.1145mg/PUFF0.11450.1145mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL207-19-2023Week 243
27TOB07PT111PUFFMASTER3KCondition 3237NON-INTENSE REGIMENNICOTINENicotine0.1157mg/PUFF0.11570.1157mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL307-19-2023Week 243

Details of the storage conditions are represented in the ES dataset. The variable STOCONID/Storage Condition ID represents the storage condition and links to the PT datasets by matching values of STOCONID there. Each of the parameters defining that storage condition are represented in ESPARMCD/ESPARM, with values and units shown in ESVAL/ESVALU. The ES dataset shows all 3 sets of storage conditions used across both of the PT dataset examples.

Dataset wrap
Namees
Dataset2
RowSTUDYIDDOMAINSTOCONIDESSEQESPARMCDESPARMESVALESVALU
1

TOB07

ESCondition 11HUMIDHumidity37%
2

TOB07

ESCondition 12TEMPTemperature24C
3

TOB07

ESCondition 21HUMIDHumidity60%
4

TOB07

ESCondition 22TEMPTemperature27C
5

TOB07

ESCondition 31HUMIDHumidity95%
6

TOB07

ESCondition 32TEMPTemperature31C
Dataset wrap
Namept
9
Rowcaps
Rows 1-9:Show the PTTEST of Nicotine for E-Liquid Standard (Long Term) Condition which is shown in PTTSTCND. The sample of various timepoints that may be used in the testing for Nicotine is reflected in PTTPT. The PTTPTNUM shows the numerical version of the planned timepoint.  The REPNUM shows the incidence number of a test that is repeated within a given timeframe for the same test.
Rows 10-19:Show the PTTEST of Nicotine for E-Vapor Standard Aerosol Condition across the same timepoints.  The PTGRPID is used to tie together a block of related records in a single domain.
Rows 20-27:Show the PTTEST of Nicotine for E-Vapor Intense Aerosol Condition across the same timepoints.  The PTGRPID is used to tie together a block of related records in a single domain.
Dataset2
Row

STUDYID

DOMAINPTSEQPTREFIDPTGRPIDPTTESTCDPTTESTPTTSTCNDPTORRESPTORRESUPTSTRESCPTSTRESNPTSTRESUPTSPECPTSPCCNDPTMETHODPTREPNUMPTTPTPTTPTNUM
1TOB07PT211VAP77777.11NIC

Nicotine

E-Liquid Standard (Long Term) Conditionmg/mLmg/mLE-LIQUID1Week 012TOB07PT212VAP77777.11

NIC

NicotineE-Liquid Standard (Long Term) Conditionmg/mLmg/mLE-LIQUID2Week 013TOB07PT213VAP77777.11NICNicotineE-Liquid Standard (Long Term) Conditionmg/mLmg/mLE-LIQUID3Week 014TOB07PT214VAP77777.11NICNicotineE-Liquid Standard (Long Term) Conditionmg/mLmg/mLE-LIQUID1Week 2445TOB07PT215VAP77777.11NICNicotineE-Liquid Standard (Long Term) Conditionmg/mLmg/mLE-LIQUID2Week 2446TOB07PT216VAP77777.11NICNicotineE-Liquid Standard (Long Term) Conditionmg/mLmg/mLE-LIQUID3Week 2447TOB07PT217VAP77777.11NICNicotineE-Liquid Standard (Long Term) Conditionmg/mLmg/mLE-LIQUID1Week 5298TOB07PT218VAP77777.11NICNicotineE-Liquid Standard (Long Term) Conditionmg/mLmg/mLE-LIQUID2Week 5299TOB07PT219VAP77777.11NICNicotineE-Liquid Standard (Long Term) Conditionmg/mLmg/mLE-LIQUID3Week 52910TOB07PT220VAP77777.13NIC

Nicotine

E-Vapor Standard Aerosol Conditionmg/puffmg/puffAEROSOL1Week 0111TOB07PT221VAP77777.13NICNicotineE-Vapor Standard Aerosol Conditionmg/puffmg/puffAEROSOL2Week 0112TOB07PT222VAP77777.13NICNicotineE-Vapor Standard Aerosol Conditionmg/puffmg/puffAEROSOL3Week 0113TOB07PT223VAP77777.13NICNicotineE-Vapor Standard Aerosol Conditionmg/puffmg/puffAEROSOL1Week 24414TOB07PT224VAP77777.13NICNicotineE-Vapor Standard Aerosol Conditionmg/puffmg/puffAEROSOL2Week 24415TOB07PT225VAP77777.13NICNicotineE-Vapor Standard Aerosol Conditionmg/puffmg/puffAEROSOL3Week 24416TOB07PT226VAP77777.13NICNicotineE-Vapor Standard Aerosol Conditionmg/puffmg/puffAEROSOL1Week 52917TOB07PT227VAP77777.13NICNicotineE-Vapor Standard Aerosol Conditionmg/puffmg/puffAEROSOL2Week 52918TOB07PT228VAP77777.13NICNicotineE-Vapor Standard Aerosol Conditionmg/puffmg/puffAEROSOL3Week 52919TOB07PT229VAP77777.13NICNicotineE-Vapor Standard Aerosol Conditionmg/puffmg/puffAEROSOL1Week 0120TOB07PT230VAP77777.14NICNicotineE-Vapor Intense Aerosol Conditionmg/puffmg/puffAEROSOL2Week 0121TOB07PT231VAP77777.14NICNicotineE-Vapor Intense Aerosol Conditionmg/puffmg/puffAEROSOL3Week 0122TOB07PT232VAP77777.14NICNicotineE-Vapor Intense Aerosol Conditionmg/puffmg/puffAEROSOL1Week 24423TOB07PT233VAP77777.14NICNicotineE-Vapor Intense Aerosol Conditionmg/puffmg/puffAEROSOL2Week 24424TOB07PT234VAP77777.14NICNicotineE-Vapor Intense Aerosol Conditionmg/puffmg/puffAEROSOL3Week 24425TOB07PT235VAP77777.14NICNicotineE-Vapor Intense Aerosol Conditionmg/puffmg/puffAEROSOL1Week 52926TOB07PT236VAP77777.14NICNicotineE-Vapor Intense Aerosol Conditionmg/puffmg/puffAEROSOL2Week 52927TOB07PT237VAP77777.14NICNicotineE-Vapor Intense Aerosol Conditionmg/puffmg/puffAEROSOL3Week 52